Edwards Lifesciences

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• JPMorgan Adjusts Price Target on Edwards Lifesciences to $105 From $100, Keeps Overweight Rating (öffnet in neuem Tab)

  marketscreener.com · 02.10.2026

• Edwards Lifesciences wins FDA approval for AUTUS (öffnet in neuem Tab)

  Mugglehead Investment Magazine · 02.10.2026

• Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients (öffnet in neuem Tab)

  Business Wire · 01.10.2026

• Edwards Lifesciences Receives FDA Approval For AUTUS Size-Adjustable Valve (öffnet in neuem Tab)

  marketscreener.com · 01.10.2026

• Wall Street Zen downgrades Edwards Lifesciences stock to Hold (öffnet in neuem Tab)

  AD HOC NEWS · 01.10.2026

• Non-operating income (total) of Edwards Lifesciences Corporation – HAN:EWL (öffnet in neuem Tab)

  TradingView · 29.09.2026

• Edwards Lifesciences stock at USD 86.83 on September 28, 2026 (öffnet in neuem Tab)

  AD HOC NEWS · 28.09.2026

• Edwards Lifesciences stock last at USD 86.52, up 0.92 percent in New York trading (öffnet in neuem Tab)

  AD HOC NEWS · 25.09.2026

• Edwards Lifesciences stock falls 1.26 percent on legal news (öffnet in neuem Tab)

  AD HOC NEWS · 24.09.2026

• Edwards Lifesciences stock heads into the open after market drop (öffnet in neuem Tab)

  AD HOC NEWS · 24.09.2026

• Andra AP fonden Boosts Stake in Edwards Lifesciences Corporation $EW (öffnet in neuem Tab)

  MarketBeat · 23.09.2026

• Edwards Lifesciences stock gains 1.26 percent near its yearly high (öffnet in neuem Tab)

  AD HOC NEWS · 22.09.2026

• Edwards Lifesciences stock holds steady after July-quarter earnings beat (öffnet in neuem Tab)

  AD HOC NEWS · 21.09.2026

• Edwards Lifesciences stock before the bell after a 0.0 percent move. (öffnet in neuem Tab)

  AD HOC NEWS · 21.09.2026

• Nykredit A S Makes New Investment in Edwards Lifesciences Corporation $EW (öffnet in neuem Tab)

  MarketBeat · 20.09.2026

• Edwards Lifesciences stock gains 4 percent as CMS decision underpins growth story (öffnet in neuem Tab)

  AD HOC NEWS · 17.09.2026

• Edwards Lifesciences Sees TAVR Expansion, $2B TMTT Opportunity Ahead (öffnet in neuem Tab)

  TradingView · 17.09.2026

• Bank of America Corp DE Takes $605.40 Million Position in Edwards Lifesciences Corporation $EW (öffnet in neuem Tab)

  MarketBeat · 16.09.2026

• Edwards Lifesciences stock steadies after insider tax-withholding transactions (öffnet in neuem Tab)

  AD HOC NEWS · 15.09.2026

• Stock Traders Purchase Large Volume of Edwards Lifesciences Call Options (NYSE:EW) (öffnet in neuem Tab)

  MarketBeat · 14.09.2026

• Corient Private Wealth LP Acquires 227,947 Shares of Edwards Lifesciences Corporation $EW (öffnet in neuem Tab)

  MarketBeat · 14.09.2026

• Engineers Gate Manager LP Sells 81,590 Shares of Edwards Lifesciences Corporation $EW (öffnet in neuem Tab)

  MarketBeat · 11.09.2026

• Edwards Lifesciences Comments on TAVR National Coverage Decision (öffnet in neuem Tab)

  Business Wire · 10.09.2026

• Edwards Lifesciences praises CMS NCD on transcatheter aortic valve replacement (öffnet in neuem Tab)

  Seeking Alpha · 10.09.2026

• Is Edwards Lifesciences Stock Underperforming the Dow? (öffnet in neuem Tab)

  Yahoo Finance · 08.09.2026

• Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders? (öffnet in neuem Tab)

  PR Newswire · 07.09.2026

• Edwards Lifesciences Corporation $EW Shares Acquired by Saudi Central Bank (öffnet in neuem Tab)

  MarketBeat · 07.09.2026

• Edwards Lifesciences: $20 Billion TAM And A Meaningful Opportunity To Compound (NYSE:EW) (öffnet in neuem Tab)

  Seeking Alpha · 07.09.2026

• Vancity Investment Management Ltd Boosts Stake in Edwards Lifesciences Corporation $EW (öffnet in neuem Tab)

  MarketBeat · 07.09.2026

• Azimuth Capital Investment Management LLC Decreases Stock Position in Edwards Lifesciences Corporation $EW (öffnet in neuem Tab)

  MarketBeat · 06.09.2026